277 related articles for article (PubMed ID: 15126102)
41. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.
Gurrieri C; Piazza F; Gnoato M; Montini B; Biasutto L; Gattazzo C; Brunetta E; Cabrelle A; Cinetto F; Niero R; Facco M; Garbisa S; Calabrese F; Semenzato G; Agostini C
J Pharmacol Exp Ther; 2010 Mar; 332(3):785-94. PubMed ID: 19959748
[TBL] [Abstract][Full Text] [Related]
42. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Nici L; Santos-Moore A; Kuhn C; Calabresi P
Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
[TBL] [Abstract][Full Text] [Related]
43. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
44. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
[TBL] [Abstract][Full Text] [Related]
45. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
Wuyts WA; Willems S; Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Rinaldi M; Vanhooren HM; Geudens N; Verleden SE; Demedts MG; Thomeer M; Verbeken EK; Verleden GM
Exp Lung Res; 2010 Dec; 36(10):602-14. PubMed ID: 20874225
[TBL] [Abstract][Full Text] [Related]
46. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
47. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
[TBL] [Abstract][Full Text] [Related]
48. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
[TBL] [Abstract][Full Text] [Related]
49. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
Keane MP; Belperio JA; Arenberg DA; Burdick MD; Xu ZJ; Xue YY; Strieter RM
J Immunol; 1999 Nov; 163(10):5686-92. PubMed ID: 10553099
[TBL] [Abstract][Full Text] [Related]
50. Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen.
Qiu Z; Fujimura M; Kurashima K; Nakao S; Mukaida N
Clin Exp Allergy; 2004 Aug; 34(8):1321-8. PubMed ID: 15298576
[TBL] [Abstract][Full Text] [Related]
51. Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on bleomycin-induced lung injury in mice.
Tajima S; Bando M; Yamasawa H; Ohno S; Moriyama H; Terada M; Takada T; Suzuki E; Gejyo F; Sugiyama Y
Respirology; 2007 Nov; 12(6):814-22. PubMed ID: 17986108
[TBL] [Abstract][Full Text] [Related]
52. Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice.
Xu B; Aoyama K; Kusumoto M; Matsuzawa A; Butcher EC; Michie SA; Matsuyama T; Takeuchi T
Int Immunol; 2007 Jun; 19(6):775-84. PubMed ID: 17513879
[TBL] [Abstract][Full Text] [Related]
53. Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice.
Kamata H; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Shinoda H; Kimizuka Y; Fujiwara H; Ishii M; Hasegawa N; Takamiya R; Fujishima S; Takano H; Ishizaka A
Exp Biol Med (Maywood); 2011 Mar; 236(3):315-24. PubMed ID: 21427237
[TBL] [Abstract][Full Text] [Related]
54. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis.
Belperio JA; Dy M; Burdick MD; Xue YY; Li K; Elias JA; Keane MP
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):419-27. PubMed ID: 12356575
[TBL] [Abstract][Full Text] [Related]
55. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
Hagiwara SI; Ishii Y; Kitamura S
Am J Respir Crit Care Med; 2000 Jul; 162(1):225-31. PubMed ID: 10903246
[TBL] [Abstract][Full Text] [Related]
56. IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation.
Dong Z; Lu X; Yang Y; Zhang T; Li Y; Chai Y; Lei W; Li C; Ai L; Tai W
BMC Pulm Med; 2015 Feb; 15():13. PubMed ID: 25888222
[TBL] [Abstract][Full Text] [Related]
57. Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation.
Griesenbach U; Cassady RL; Cain RJ; duBois RM; Geddes DM; Alton EW
Gene Ther; 2002 Aug; 9(16):1109-15. PubMed ID: 12140739
[TBL] [Abstract][Full Text] [Related]
58. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
[TBL] [Abstract][Full Text] [Related]
59. Mizoribine protects against bleomycin-induced lung injury.
Matsui K; Ueda H; Terada M; Azuma N; Okamura H; Sano H
Mod Rheumatol; 2010 Oct; 20(5):471-7. PubMed ID: 20490597
[TBL] [Abstract][Full Text] [Related]
60. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
